USA - NASDAQ:NUTX - US67079U3068 - Common Stock
The current stock price of NUTX is 111 USD. In the past month the price increased by 11.32%. In the past year, price increased by 356.98%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
HCA | HCA HEALTHCARE INC | 18.09 | 101.35B | ||
THC | TENET HEALTHCARE CORP | 13.7 | 17.86B | ||
UHS | UNIVERSAL HEALTH SERVICES-B | 11.01 | 13.19B | ||
EHC | ENCOMPASS HEALTH CORP | 25.19 | 12.61B | ||
ENSG | ENSIGN GROUP INC/THE | 30.95 | 10.70B | ||
SGRY | SURGERY PARTNERS INC | 24.82 | 2.67B | ||
CON | CONCENTRA GROUP HOLDINGS PAR | 16.4 | 2.59B | ||
ACHC | ACADIA HEALTHCARE CO INC | 8.62 | 2.21B | ||
ARDT | ARDENT HEALTH INC | 8.21 | 2.10B | ||
BKD | BROOKDALE SENIOR LIVING INC | N/A | 2.08B | ||
PACS | PACS GROUP INC | 16.68 | 1.97B | ||
NHC | NATIONAL HEALTHCARE CORP | 18.39 | 1.91B |
Nutex Health, Inc. engages in the management and operation of healthcare facilities. The company is headquartered in Houston, Texas and currently employs 830 full-time employees. The company went IPO on 2011-03-18. The firm operates in three segments: the Hospital division, the Population Health Management (PHM) division, and the Real Estate division. The Hospital division owns, develops and operates healthcare models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 24 facilities in 11 states. In addition, it has financial and operating relationships with multiple professional entities and real estate entities. The Population Health Management division owns and operates provider networks, such as Independent Physician Associations (IPAs). Through its Management Services Organization (MSO), it provides management, administrative and other support services to its affiliated hospitals and physician groups. The Real Estate division comprises the Real Estate Entities, which owns the land and hospital buildings which are leased to its hospital entities.
NUTEX HEALTH INC
6030 S. Rice Ave., Suite C
Houston TEXAS US
Employees: 830
Phone: 17136600557
The current stock price of NUTX is 111 USD. The price increased by 17.05% in the last trading session.
The exchange symbol of NUTEX HEALTH INC is NUTX and it is listed on the Nasdaq exchange.
NUTX stock is listed on the Nasdaq exchange.
9 analysts have analysed NUTX and the average price target is 246.5 USD. This implies a price increase of 122.07% is expected in the next year compared to the current price of 111. Check the NUTEX HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
NUTEX HEALTH INC (NUTX) has a market capitalization of 617.16M USD. This makes NUTX a Small Cap stock.
NUTEX HEALTH INC (NUTX) currently has 830 employees.
NUTEX HEALTH INC (NUTX) has a support level at 102.77 and a resistance level at 111.01. Check the full technical report for a detailed analysis of NUTX support and resistance levels.
The Revenue of NUTEX HEALTH INC (NUTX) is expected to grow by 186.75% in the next year. Check the estimates tab for more information on the NUTX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
NUTX does not pay a dividend.
NUTEX HEALTH INC (NUTX) will report earnings on 2025-11-05.
The PE ratio for NUTEX HEALTH INC (NUTX) is 9.34. This is based on the reported non-GAAP earnings per share of 11.89 and the current share price of 111 USD. Check the full fundamental report for a full analysis of the valuation metrics for NUTX.
The outstanding short interest for NUTEX HEALTH INC (NUTX) is 28.86% of its float. Check the ownership tab for more information on the NUTX short interest.
ChartMill assigns a technical rating of 7 / 10 to NUTX. When comparing the yearly performance of all stocks, NUTX is one of the better performing stocks in the market, outperforming 98.27% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to NUTX. Both the profitability and the financial health of NUTX get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months NUTX reported a non-GAAP Earnings per Share(EPS) of 11.89. The EPS increased by 430.28% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 10.76% | ||
ROA | 8.82% | ||
ROE | 34.08% | ||
Debt/Equity | 1.46 |
9 analysts have analysed NUTX and the average price target is 246.5 USD. This implies a price increase of 122.07% is expected in the next year compared to the current price of 111.
For the next year, analysts expect an EPS growth of -60.63% and a revenue growth 186.75% for NUTX